SCHEMBL222264

SCHEMBL222264

COC(=O)c1ccc(NC(=O)[C@H]2N[C@@H](CC(C)(C)C)[C@@]3(C(=O)Nc4cc(Cl)ccc43)[C@H]2c2ccc(F)c(Cl)c2)c(OC)c1

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 20/20 0.70
TP53 P04637 4/20 0.70
MDM4 O15151 4/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222265 1.00 MDM2 (0.70) MDM2TP53MDM4
SCHEMBL222575 1.00 MDM2 (0.70) MDM2TP53MDM4
SCHEMBL222576 1.00 MDM2 (0.70) MDM2TP53MDM4
SCHEMBL222322 0.94 MDM2 (0.78) MDM2TP53MDM4
SCHEMBL222321 0.94 MDM2 (0.78) MDM2TP53MDM4
SCHEMBL786827 0.94 MDM2 (0.78) MDM2TP53MDM4
SCHEMBL16787967 0.92 MDM2 (0.65) MDM2TP53MDM4
SCHEMBL222842 0.91 MDM2 (0.70) MDM2TP53MDM4
SCHEMBL222843 0.91 MDM2 (0.70) MDM2TP53MDM4
SCHEMBL222172 0.90 MDM2 (0.68) MDM2TP53MDM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088815-B2 Spiroindolinone pyrrolidines HOFFMAN-LA ROCHE INC. (US) 2012-01-03 US disclosed
US-20110130398-A1 SPIROINDOLINONE PYRROLIDINES BARTKOVITZ DAVID JOSEPH 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130398-A1 SPIROINDOLINONE PYRROLIDINES RPS4Y1, RB1, RPS4X MDM2 1419/4885TP53 199/4885MDM4 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.